-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Analyst Opinions
NewBeyond Bytes – Data Center Evolution for Peak Performance
GlobalData's Innovation Radar report, "Beyond Bytes: Data Center Evolution for Peak Performance," provides a comprehensive look at the latest trends in data center infrastructure. It explores advancements aimed at improving efficiency, scalability, and sustainability. The report emphasizes the role of technologies like AI, edge computing, and advanced cooling solutions in creating resilient and eco-friendly data centers. With strategic insights and real-world applications, this report is essential for businesses looking to leverage the latest data center technologies for a competitive edge.
-
Thematic Analysis
NewCloud Computing in Travel and Tourism – Thematic Intelligence
Computing in Travel and Tourism - Thematic Intelligence The travel and tourism industry has undergone a sea change in the last few years, moving away from brick-and-mortar travel agents towards online travel. Cloud technologies are the bedrock enabling this change. Cloud investment by travel and leisure companies will reach a significant value by 2028. At its core, cloud computing speeds up product delivery, reducing the time to market. It is also scalable, meaning companies can pay for the exact storage...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Small Cell Lung Carcinoma
Overview How likely is it that the drugs in Non-Small Cell Lung Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Small Cell Lung Carcinoma Overview Non-small cell lung carcinoma (NSCLC)...
-
Sector Analysis
NewBusiness of Major League Soccer 2024 – Property Profile, Sponsorship and Media Landscape
Reasons to buy the ‘Business of Major League Soccer’ report: Analyze the Major League Soccer (MLS) 2024 with a clear breakdown of the commercial partnerships. Get an overview of the Soccer League Social Media which includes the MLS League Social Media Breakdown and Team Social Media Breakdown. Gain insights on the League Sponsorship including Commercial Portfolio and League Sponsor Values. Examine the biggest deals of MLS 2024 and get an insightful deal analysis in terms of industry and brand location....
-
Thematic Analysis
NewGlobal M&A Deals in Q1 2024 – Top Themes by Sector – Thematic intelligence
The global M&A market in Q1 2024 witnessed deals worth $613 billion, a rise of 38% compared to Q1 2024. In terms of deal volume, there was a 13% fall from 8,468 deals in Q1 2023 to 7,248 M&A deals in Q1 2024. The TMT sector led the M&A deal activity, with 2,163 deals worth $186 billion recorded in Q1 2024. Most sectors saw a year-on-year increase in deal activity in Q1 2024. Mega-deals (defined as any deal valued at...
-
Consumer Insights
NewMass Affluent Banking in Greater China – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
Mass Affluent Banking Market in Greater China Report Overview Emerging affluents and mass affluents make up most of the affluent population in the Greater China region. The population of affluents has been exponential in the last decade in the region. However, the growth is expected to slow down in the upcoming years as the economies mature. Despite low growth, the number of mass affluent customers in the region is exceedingly large, offering a huge market to the financial providers looking...
-
Product Insights
NewLikelihood of Approval Analysis for Sezary Syndrome
Overview How likely is it that the drugs in Sezary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sezary Syndrome Overview Sezary syndrome is an erythrodermic cutaneous T-cell lymphoma with...
-
Product Insights
NewLikelihood of Approval Analysis for Salmonella Infections
Overview How likely is it that the drugs in Salmonella Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salmonella Infections Overview Salmonellosis is a symptomatic infection caused by bacteria of...